Later studies corroborated a positive association between T. vaginalis seropositivity and prostate cancer risk [25,26] as well as between T. vaginalis seropositivity and higher prostate-specific antigen (PSA) levels and tumor stage [25]. Here, KLK3 is linked to prostate cancer.